Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
3
×
fremanezumab
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
calcitonin gene-related peptide
eptinezumab
erenumab
fda
galcanezumab
migraine
migraine research foundation
novartis
What
approval
3
×
drug
new
class
companies
fda
migraine
won
amgen
arguments
big
bio
biogen’s
biopharmaceutical
candidates
commercialized
competitors
convo
decades
developed
drugs
earlier
failures
gets
head
littered
make
medicines
meeting
nash
neuro
news
nod
oral
pain
potential
preventive
price
remains
road
Language
Current search:
national
×
biotech
×
approval
×
" eli lilly "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines